Somerset, N.J. (PRWEB) August 28, 2014
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Kristen DeVito, Global Director Clinical Supply Services, and Chris Greco, Manager, Comparator and Ancillary Supplies, will present “Critical Path Sourcing Strategies for Active Control Clinical Trials” at the forthcoming US Clinical Trials Supply Conference, which takes place on the 9th – 10th September, 2014 in Philadelphia, PA.
The jointly-presented session, on Tuesday 9th September, from 2 to 2.30 pm, will provide insight into the complex and challenging process of comparator sourcing, and maintaining supplies throughout active clinical trials. The presentation will highlight key factors in building a robust comparator sourcing strategy including understanding global regulations, forecasting changing demands and needs, and minimizing delays and waste.
Kristen DeVito is Global Director, Clinical Supply Services Business Solutions, with responsibility for both internal business improvement and Clinical Supplies Management. She has over twenty years’ experience in the industry, previously holding the role of General Manager of the former Catalent’s Clinical Supply Solutions site in Mt. Laurel, NJ, and prior to that, working for Aptuit and Quintiles. Ms. DeVito is a committee member and former Chair of the ISPE Investigational Products COP Steering Committee, and former instructor for the Center of Professional Advancement Course, Clinical Trial Materials.
Chris Greco manages the US Comparator and Ancillary Supplies services at Catalent. Prior to this role, he spent a number of years in various R&D and clinical supply groups and has led the strategic comparator sourcing activity for over 100 clinical trials. He obtained a B.S. in Chemistry from the University of Pittsburgh, and an MBA from Penn State, Smeal College of Business.
To arrange a meeting with Ms. DeVito or Mr. Greco, contact Richard Kerns at richard(at)nepr(dot)eu.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,000 people, including over 1,000 scientists, at 27 facilities across 5 continents. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com.
More products. Better treatments. Reliably supplied.™